The George Institute

This Phase 3 trial is testing different treatments to slow the worsening of chronic kidney disease (CKD) and reduce the number of people who develop kidney failure. About 1,000 adults with CKD will receive standard care plus one or more experimental agents. The goal is to find th…

This study tests whether a medicine called fludrocortisone can help people recover better after a serious brain bleed from a burst aneurysm. About 524 adults in intensive care will receive either the drug or a placebo. The goal is to see if the drug reduces death and long-term di…

This study compares two types of IV fluids—Plasma-Lyte 148 and standard saline—in adults with moderate to severe diabetic ketoacidosis (DKA) who need intensive care. The goal is to see if Plasma-Lyte 148 helps patients spend more days alive and out of the hospital within the firs…

This study tests whether giving a single dose of a common antibiotic soon after a breathing tube is placed can prevent lung infections and improve survival in people with severe brain injuries. About 3,300 adults on ventilators in intensive care will be randomly assigned to recei…

This study tests two types of non-invasive brain stimulation (tDCS and rTMS) to see if they can reduce symptoms of anorexia nervosa. 70 people with anorexia will receive either real or sham (fake) stimulation over 8 weeks. The goal is to improve eating disorder symptoms, mood, an…